Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Research & Development (2021 - 2025)

Tenon Medical (TNON) has 5 years of Research & Development data on record, last reported at $428000.0 in Q3 2025.

  • For Q3 2025, Research & Development fell 34.86% year-over-year to $428000.0; the TTM value through Sep 2025 reached $2.2 million, down 19.6%, while the annual FY2024 figure was $2.6 million, 17.7% down from the prior year.
  • Research & Development reached $428000.0 in Q3 2025 per TNON's latest filing, down from $503000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $901000.0 in Q2 2023 and bottomed at $87000.0 in Q1 2021.
  • Average Research & Development over 5 years is $628105.3, with a median of $669000.0 recorded in 2024.
  • Peak YoY movement for Research & Development: soared 545.98% in 2022, then crashed 34.86% in 2025.
  • A 5-year view of Research & Development shows it stood at $793000.0 in 2021, then grew by 2.4% to $812000.0 in 2022, then decreased by 14.9% to $691000.0 in 2023, then fell by 17.66% to $569000.0 in 2024, then decreased by 24.78% to $428000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $428000.0 in Q3 2025, $503000.0 in Q2 2025, and $691000.0 in Q1 2025.